Launched in 2004, the Convergence Forum has become a premier event, consistently convening high-level healthcare executives and thought leaders to discuss and debate the most pressing topics facing the industry. As a critical platform, the Forum’s primary function is to foster collaborative dialogue around the challenges and opportunities that shape the future of medicine, ensuring participants stay ahead of the rapid changes defining the global health landscape.

The Forum’s discussions are focused on both strategic operations and future technological trends. Key themes debated include the challenges of forging strong corporate partnerships, attracting essential funding from both private and public sources, and establishing successful research organizations. Additionally, the agenda delves into practical matters like streamlining product development and regulatory approval pathways, while also dedicating significant attention to understanding the coming convergence of biology, software, and medical devices, as well as anticipating shifts in the regulatory and reimbursement status quo.

The prestige of the Convergence Forum is reflected in its consistently high-caliber speaker roster. Past presenters have included CEOs and senior executives from industry giants such as Sanofi Genzyme, Biogen Idec, GlaxoSmithKline, Pfizer, Alnylam Pharmaceuticals, and Novartis. These commercial leaders are regularly joined by distinguished academic researchers from influential institutions, including Harvard, MIT, Tufts, and the renowned Broad Institute, ensuring a comprehensive and multidisciplinary perspective on the future of healthcare innovation.